Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial
John Vissing, Robert D. S. Pitceathly, Gráinne S. Gorman, Jeffrey S. Finman et al.
Citations
7 citations
Journal
Orphanet Journal of Rare Diseases
Topics
Mitochondrial Function and Pathology
Field-Weighted Citation Impact (FWCI)
1.64
article
Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial
John Vissing, Robert D. S. Pitceathly, Gráinne S. Gorman, Jeffrey S. Finman, Fernando Scaglia, Amy B. Goldstein, Mark A. Tarnopolsky, Mary Kay Koenig, Alana Sullivan, Jerry E. Vockley, Serenella Servidei, Thomas Klopstock, Cornelia Kornblum, Sumit Parikh, Amel Karaa, Anna Lehman, Russell P. Saneto, Anthony Abbruscato, Costanza Lamperti, Marni J. Falk, Enrico Bertini, Valério Carelli, Johan L.K. Van Hove, Mária Judit Molnár, António Toscano, David A. Brown, James A. Shiffer, Nicola Longo, Michio Hirano, Michelango Mancuso, H. Phan, Bruce M. Cohen, Richard Haas, Gregory M. Ennes
article en
7 citations
Abstract
No abstract available for this paper.
Publication Tag
Orphanet Journal of Rare DiseasesVol. 19(1)
Institutions
Semmelweis University (HU), Università Cattolica del Sacro Cuore (IT), University of Pisa (IT), University of Messina (IT), University of Copenhagen (DK), Seattle Children's Hospital (US), Cleveland Clinic (US), Children's Hospital of Philadelphia (US), Harvard University (US), University of Pittsburgh (US), Baylor College of Medicine (US), University of Utah (US), University Hospital Bonn (DE), Columbia University Irving Medical Center (US), Royal Victoria Infirmary (GB), German Center for Neurodegenerative Diseases (DE), McMaster Children's Hospital (CA), Copenhagen University Hospital (DK), Rigshospitalet (DK), Vancouver General Hospital (CA), University of California San Diego (US), Massachusetts General Hospital (US), Children's Hospital Colorado (US), Akron Children's Hospital (US), Munich Cluster for Systems Neurology (DE), Prince of Wales Hospital (CN), Jupiter Medical Center (US), Istituto delle Scienze Neurologiche di Bologna (IT), Bambino Gesù Children's Hospital (IT), Rare Disease Therapeutics (United States) (US), Children's Hospital of Pittsburgh (US), Friedrich Baur Stiftung (DE), Stealth BioTherapeutics (United States) (US), Texas Children's Hospital (US), National Hospital for Neurology and Neurosurgery (GB), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Fondazione IRCCS Istituto Neurologico Carlo Besta (IT), University College London (GB), University of Pennsylvania (US), Ludwig-Maximilians-Universität München (DE), University of Hong Kong (HK), The University of Texas Health Science Center at Houston (US), University of Colorado Denver (US), University of Bologna (IT), Stanford University (US), McMaster University (CA)